2m 2m 2m 2m 2m 2m 2m
CURANEX PHARMA (CURX)
NASDAQ
$0.34+$0.01 (+3.84%)
Price as of Jun 03, 2026 6:16 PM EDT- $9.4MMarket Cap
- N/A1-Year Change
- BiotechnologyIndustry
CURANEX PHARMA (CURX)
$0.34+$0.01 (+3.84%)
CURX | vs History | vs S&P 500 | |
|---|---|---|---|
General Statistics | |||
Latest Close | $0.33 | ||
Change | -$0.02 (-4.52%) | ||
Open | $0.34 | ||
High | $0.35 | ||
Low | $0.32 | ||
Previous Close | $0.34 | ||
Volume | 40,622 | ||
30-Day Average Volume | 88,063 | ||
1-Week Change | -5.10% | ||
1-Month Change | -12.03% | ||
1-Year Change | N/A | ||
3-Year Change | N/A | ||
5-Year Change | N/A | ||
Fundamentals | |||
Shares Outstanding | 28.4M | ||
Total Assets | $8.4M | ||
Market Cap | $9.4M | ||
Enterprise Value | $5.4M | ||
Period: QTR TTM FY | |||
Revenue | N/A | ||
Net Income | N/A | ||
Free Cash Flow | -$954,560.00 | ||
EBIT | $0.00 | ||
EBITDA | $0.00 | ||
Net Working Capital | N/A | ||
EPS | -$0.11 | ||
Enterprise Value/EBITDA | N/A | ||
Enterprise Value/Revenue | N/A | ||
P/B | N/A | ||
P/E | -3 | ||
PEG | 0 | ||
Price/Free Cash Flow | -10 | ||
Price/Operating Cash Flow | -10 | ||
Dividends & Splits | |||
Forward Annual Dividend Yield | N/A | ||
Trailing Annual Dividend Yield | N/A | ||
Ex-Dividend Date | N/A | ||
Last Split Factor | N/A | ||
Last Split Date | N/A | ||
Earnings & Revenue